<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) is an <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e> of an unknown cause, but growing evidence indicates that the <z:mp ids='MP_0003674'>oxidative stress</z:mp> is increased in BD, owing to the overproduction of reactive oxygen species (ROS) and decreased efficiency of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defenses </plain></SENT>
<SENT sid="1" pm="."><plain>ROS affect proteins and <z:chebi fb="23" ids="18059">lipids</z:chebi> and cause their oxidation, therefore, contributing to the formation of oxidation products: <z:chebi fb="1" ids="23019">carbonyl</z:chebi>, a marker of protein oxidation, and malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), a marker of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation </plain></SENT>
<SENT sid="2" pm="."><plain>The investigation was undertaken to evaluate protein oxidation (<z:chebi fb="0" ids="23019">carbonyl group</z:chebi>) levels and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (<z:chebi fb="14" ids="32506">MDA</z:chebi>) levels, and the role of <z:chebi fb="0" ids="23359">colchicine</z:chebi> and vitamin E therapy on protein <z:chebi fb="0" ids="23019">carbonyl group</z:chebi> and <z:chebi fb="14" ids="32506">MDA</z:chebi> levels in serum samples of patients with BD </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, subjects were classified as control group, <z:chebi fb="0" ids="23359">colchicine</z:chebi> therapy group alone and <z:chebi fb="0" ids="23359">colchicine</z:chebi> and vitamin E therapy group </plain></SENT>
<SENT sid="4" pm="."><plain>Protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi> and <z:chebi fb="14" ids="32506">MDA</z:chebi> levels at the beginning of the study were significantly (p &lt; 0.05) higher in both therapy groups compared with those of the control group </plain></SENT>
<SENT sid="5" pm="."><plain>We found that the protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi> and <z:chebi fb="14" ids="32506">MDA</z:chebi> levels at the end of the study showed no significant (p &gt; 0.05) differences between the therapy groups and control group </plain></SENT>
<SENT sid="6" pm="."><plain>These results provide some evidence for a potential effect of <z:chebi fb="0" ids="23359">colchicine</z:chebi> and vitamin E therapies on increased protein oxidation and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in BD </plain></SENT>
</text></document>